Chimeric Antigen Receptor T Cell Therapy Report

By www.regionalmarketresearch.com

Report Details

Report Name

Global Chimeric Antigen Receptor T Cell Therapy Market Research Report 2024 Story

Pages

95

Price

$ 2900

Features

Chimeric Antigen Receptor T Cell Therapy Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Amgen
Bellicum Pharmaceuticals
Bluebird Bio
Caribou Biosciences
Celgene Corporation
Cellectis
Celyad Oncology
Gilead Sciences
Intellia Therapeutics
Johnson & Johnson
Legend Biotech
Merck
Noile-Immune Biotech
Novartis
Pfizer
Sangamo Therapeutics
Servier Laboratories